François Vaillant, James Whittle, and Delphine Merino (IMAGE)

Walter and Eliza Hall Institute

François Vaillant, James Whittle, and Delphine Merino

Caption

A new class of anti-cancer agents that target cancer cells' 'Achilles' heel' could help to supercharge breast cancer treatment, improving outcomes for some of the most aggressive types of breast cancer. A research team from the Walter and Eliza Hall Institute in Melbourne, Australia, found that combining anti-cancer compound S63845 with currently used cancer drugs was more effective in killing triple negative breast cancers and HER2-positive breast cancers. L-R: Dr François Vaillant, Dr James Whittle and Dr Delphine Merino

Credit

Walter and Eliza Hall Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.